Pharmaceutical Grade Vonoprazan Fumarate Raw Material Vonoprazan Fumarate Powder Vonoprazan Fumarate

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Model NO.: D-sung Vonoprazan Fumarate
• Product Name: Vonoprazan Fumarate
• Name: Vonoprazan Fumarate Powder
• Appearance: White Powder
• Color: White Color
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 881681-01-2
• Mf: C21h20fn3o6s
• MW: 461.4634032
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

Pharmaceutical Grade Vonoprazan Fumarate Raw Material Vonoprazan Fumarate Powder Vonoprazan Fumarate

Product Description

Product Details

Product name	Vonoprazan Fumarate
Appearance	White powder
CAS NO.	881681-01-2
MF	C21H20FN3O6S
MW	461.4634032

Vonoprazan Fumarate is a new type of potassium ion (K+) competitive acid blocker (P-CAB), which can produce a strong and lasting inhibition of gastric acid secretion by competitively inhibiting the binding of K+and H+- K+- ATPase (proton pump) at the final step of gastric parietal cells secreting gastric acid. The drug is applicable to gastric ulcer, duodenal ulcer, reflux esophagitis, erosive esophagitis, gastroesophageal reflux disease, helicobacter infection and peptic ulcer.

Application&Function

It is a relatively new proton pump inhibitor. Global approved indications include digestive esophagitis; Helicobacter infection; Duodenal ulcer; Esophagitis; gastric ulcer; Gastroesophageal reflux disease; Peptic ulcer.Vonorazan fumarate is a reversible proton pump inhibitor, also known as potassium ion competitive acid blocker. It competitively blocks the K+binding site of H+, K+- ATPase (proton pump) and inhibits the binding of K+to H+, K+- ATPase (proton pump), thus inhibiting gastric acid secretion.

Vonorazan fumarate has a strong and continuous inhibitory effect on gastric acid secretion. Compared with ordinary gastric acid inhibitors such as omeprazole and lansoprazole, this product is stable in gastric acid and can be prepared with ordinary preparations without enteric coating. It takes effect quickly and takes a long time.
Compared with traditional irreversible proton pump inhibitors (such as omeprazole, esomeprazole, etc.), reversible proton pump inhibitors have the following advantages:; (2) Oral administration is not affected by gastric acid and does not need to be made into enteric drug delivery form; (3) It can improve the acid breakthrough at night.

Specification